Download Files:
Products Details
Product Description
– HBV-IN-12 is a potent hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). HBV-IN-12 shows anti-HBV DNA activity (0.001 μM＜EC50 ≤0.02 μM). From patent WO2021204252A1, compound 15[1].
Web ID
– HY-145059
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H27NO8
References
– [1]Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1.
CAS Number
– 2724229-06-3
Molecular Weight
– 445.46
SMILES
– CC(C)([C@H]1N2C(C3=C(OC1)C=C(OCCCOC)C4=C3OCO4)=CC(C(C(O)=O)=C2)=O)C
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
